• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

监测透析结果(MONDO)联盟中全球人口健康指标与透析变量之间的关联。

Associations between global population health indicators and dialysis variables in the Monitoring Dialysis Outcomes (MONDO) consortium.

作者信息

Calice-Silva Viviane, Hussein Rasha, Yousif Dalia, Zhang Hanjie, Usvyat Len, Campos Ludimila G, von Gersdorff Gero, Schaller Mathias, Marcelli Danielle, Grassman Aileen, Etter Michael, Xu Xiaoqi, Kotanko Peter, Pecoits-Filho Roberto

机构信息

School of Medicine, Pontificia Universidade Católica do Paraná, Curitiba, Brazil.

出版信息

Blood Purif. 2015;39(1-3):125-36. doi: 10.1159/000368980. Epub 2015 Jan 20.

DOI:10.1159/000368980
PMID:25659840
Abstract

BACKGROUND

The number of patients receiving renal replacement therapy (RRT) increases annually and worldwide. Differences in the RRT incidence, prevalence, and modality vary between regions and countries for reasons yet to be clarified.

AIMS

Gain a better understanding of the association between hemodialysis (HD)-related variables and general population global health indicators.

METHODS

The present study included prevalent HD patients from 27 countries/regions from the monitoring dialysis outcomes (MONDO) database from 2006-2011. Global population health indicators were obtained from the 2014 World Health Organization report and the Human Development Index from the Human Development Report Office 2014. The Spearman rank test was used to assess the correlations between population social economic indicators and HD variables.

RESULTS

A total of 84,796 prevalent HD patients were included. Their mean age was 63 (country mean 52-71), and 60% were males (country mean 52-85%). Significant correlations were found between HD demographic clusters and population education, wealth, mortality, and health indicators. The cluster of nutrition and inflammation variables were also highly correlated with population mortality, wealth, and health indicators. Finally, cardiovascular, fluid management, and dialysis adequacy clusters were associated with education, wealth, and health care resource indicators.

CONCLUSION

We identified socioeconomic indicators that were correlated with dialysis variables. This hypothesis-generating study may be helpful in the analysis of how global health indicators may interfere with access to HD, treatment provision, dialytic treatment characteristics, and outcomes.

摘要

背景

全球范围内,接受肾脏替代治疗(RRT)的患者数量逐年增加。RRT的发病率、患病率和治疗方式在不同地区和国家存在差异,原因尚待阐明。

目的

更好地理解血液透析(HD)相关变量与全球人口健康指标之间的关联。

方法

本研究纳入了2006年至2011年监测透析结果(MONDO)数据库中来自27个国家/地区的HD现患患者。全球人口健康指标来自2014年世界卫生组织报告,人类发展指数来自2014年人类发展报告办公室。采用Spearman秩和检验评估人口社会经济指标与HD变量之间的相关性。

结果

共纳入84,796例HD现患患者。他们的平均年龄为63岁(各国平均年龄为52 - 71岁),60%为男性(各国平均比例为52 - 85%)。HD人口统计学分组与人口教育、财富、死亡率和健康指标之间存在显著相关性。营养和炎症变量分组也与人口死亡率、财富和健康指标高度相关。最后,心血管、液体管理和透析充分性分组与教育、财富和医疗资源指标相关。

结论

我们确定了与透析变量相关的社会经济指标。这项产生假设的研究可能有助于分析全球健康指标如何影响HD的可及性、治疗提供、透析治疗特征和结局。

相似文献

1
Associations between global population health indicators and dialysis variables in the Monitoring Dialysis Outcomes (MONDO) consortium.监测透析结果(MONDO)联盟中全球人口健康指标与透析变量之间的关联。
Blood Purif. 2015;39(1-3):125-36. doi: 10.1159/000368980. Epub 2015 Jan 20.
2
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
3
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
4
Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.终末期肾病患者腹膜透析与血液透析的成本比较
Am J Manag Care. 2009 Aug;15(8):509-18.
5
Interdialytic weight gain and ultrafiltration rate in hemodialysis: lessons about fluid adherence from a national registry of clinical practice.血液透析中的透析间期体重增加及超滤率:来自全国临床实践登记处的液体依从性经验教训
Hemodial Int. 2009 Apr;13(2):181-8. doi: 10.1111/j.1542-4758.2009.00354.x.
6
End stage renal disease in Brunei Darussalam - report from the first Brunei Dialysis Transplant Registry (BDTR).文莱达鲁萨兰国的终末期肾病 - 来自第一份文莱透析移植登记处(BDTR)的报告。
Ren Fail. 2013 Sep;35(8):1101-4. doi: 10.3109/0886022X.2013.815101. Epub 2013 Jul 23.
7
Quality of care assessment and adherence to the international guidelines considering dialysis, water treatment, and protection against transmission of infections in university hospital-based dialysis units in Cairo, Egypt.埃及开罗大学医院透析单元的护理质量评估以及对透析、水处理和感染传播防护方面国际指南的遵循情况
Hemodial Int. 2010 Jan;14(1):61-7. doi: 10.1111/j.1542-4758.2009.00398.x. Epub 2009 Sep 16.
8
The MONitoring Dialysis Outcomes (MONDO) initiative.监测透析结局(MONDO)倡议。
Blood Purif. 2013;35(1-3):37-48. doi: 10.1159/000345179. Epub 2013 Jan 22.
9
The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective.规模经济在全球透析成本中的作用:宏观经济视角
Nephrol Dial Transplant. 2014 Apr;29(4):885-92. doi: 10.1093/ndt/gft528. Epub 2014 Feb 9.
10
Home haemodialysis-international trends and variation.家庭血液透析——国际趋势与差异
Nephrol Dial Transplant. 2006 Jul;21(7):1934-45. doi: 10.1093/ndt/gfl093. Epub 2006 Mar 14.

引用本文的文献

1
Systemic Treatment for Gynecological Cancer Patients Undergoing Hemodialysis.接受血液透析的妇科癌症患者的全身治疗。
Onco Targets Ther. 2023 Jul 8;16:545-558. doi: 10.2147/OTT.S419445. eCollection 2023.
2
Durable effect of pyrotinib plus capecitabine in HER-2+ breast cancer patient undergoing peritoneal dialysis: A case report and literature review.吡咯替尼联合卡培他滨对接受腹膜透析的HER-2阳性乳腺癌患者的持久疗效:一例报告及文献综述
Front Oncol. 2022 Dec 8;12:1059670. doi: 10.3389/fonc.2022.1059670. eCollection 2022.
3
Differences in the performance of adjuvant chemotherapy between hemodialysis and nonhemodialysis patients.
血液透析与非血液透析患者辅助化疗效果的差异。
Cancer Med. 2023 Feb;12(4):4033-4041. doi: 10.1002/cam4.5258. Epub 2022 Sep 21.
4
Socioeconomic status and mortality among dialysis patients: a systematic review and meta-analysis.透析患者的社会经济地位与死亡率:系统评价和荟萃分析。
Int Urol Nephrol. 2019 Mar;51(3):509-518. doi: 10.1007/s11255-019-02078-5. Epub 2019 Jan 28.
5
Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN).终末期肾病患者化疗管理:意大利医学肿瘤学会(AIOM)和意大利肾脏病学会(SIN)的建议
ESMO Open. 2017 Jul 19;2(3):e000167. doi: 10.1136/esmoopen-2017-000167. eCollection 2017.